Ronit Slotky, PhD
Advertisement
Articles by Ronit Slotky, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Full Approval to Pembrolizumab for Unresectable/Metastatic TMB-H Solid Tumors
2
Experts Tackle Key Questions on CDK4/6 Inhibition Across HR+ Breast Cancer Settings
3
Tolerability Remains a TROP2-Directed ADC Hurdle in EGFR-Mutated NSCLC
4
Pembrolizumab Plus Enfortumab Vedotin Earns EC Approval in Resectable MIBC
5